Cosmos Health has projected $6M in revenue from the launch of its Oliv18 supplement. Further details regarding the timeline or market strategy were not immediately available.
Cosmos Health targets $6M revenue from Oliv18 supplement launch
The company expects $6M in revenue from the launch of its Oliv18 supplement.
HV
Helena Vásquez · Business Desk · 24 Aug 2026 · 20:28 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
HV
Written by
Helena Vásquez
Business Desk
Helena covers corporate news for listed and private companies across Europe, from strategy shifts to leadership changes, with an eye for what a story signals about the broader market.
More from Helena Vásquez →
